Clinical trial on the QOL of the Tegafur/Uracil plus Leucovolin(UFT/LV) to adjuvant chemotherapy for the Stage II, III colorectal cancer
- Conditions
- resectable StageII, III colorectal cancer
- Registration Number
- JPRN-UMIN000008961
- Lead Sponsor
- Department of Surgery Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Not provided
1)with active synchronous or metachronous malignancy other than carcinoma in situ(within 5 years). (2)Synchronous or metachronous malignancy other than carcinoma in situ 3)has severe postoperative complications such as serious postoperative infectious disease,anastomotic leak and gastrointestinal bleeding. 4)has any of the following complications: i)Uncontrollable diabetes mellitus ii)Uncontrollable hypertension iii) heart failure within 6 months,myocardial infarction,AP or sever abnormality of ECG iv)renal failure v)interstitial pneumonitis,lung fibrosis or severe emphysema . 5)has any of the following : i)is a pregnant woman or a woman suspected of being pregnant,or,is a man who hopes to make his partner pregnant ii)nursing women 6)with psychosis or psychoneurosis. 7)In case that the doctor judged that he/she is disqualified for the enrollment in this clinical trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of Life
- Secondary Outcome Measures
Name Time Method Adverse event 3-year Disease free survival ratio